Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2675 Target Snapshot

Glutamate receptor ionotropic, kainate 5 · SINGLE PROTEIN · Homo sapiens

40Compounds
12Assays
0Approved Drugs
44.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q16478. Use UniProt Q16478 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q16478 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Glutamate receptor ionotropic, kainate 5 as ChEMBL target CHEMBL2675, mapped to UniProt Q16478. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Glutamate receptor ionotropic, kainate 5
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2675
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q16478
Glutamate receptor ionotropic, kainate 5
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Glutamate receptor ionotropic, kainate 5 is the right protein anchor across sources, using UniProt Q16478 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGlutamate receptor ionotropic, kainate 5
UniProt AccessionQ16478
Component TypeProtein
Sequence Length980 aa

Glutamate receptor ionotropic, kainate 5

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Glutamate receptor ionotropic, kainate 5, mapped to UniProt Q16478. Sequence length is 980 aa.

Mapped IDQ16478
Review nameGlutamate receptor ionotropic, kainate 5
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

KI41.0
EC503.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL121915 9.62 Ki 0.24 Preclinical
CHEMBL331644 8.54 Ki 2.9 Preclinical
CHEMBL275040 8.1 Ki 8.0 Clinical
CHEMBL333964 8.04 Ki 9.1 Preclinical
CHEMBL121553 7.7 Ki 19.8 Preclinical
CHEMBL331696 7.51 Ki 30.9 Preclinical
CHEMBL121388 7.24 Ki 57.1 Preclinical
CHEMBL29024 7.0 EC50 100.0 Preclinical
CHEMBL28472 6.89 EC50 130.0 Preclinical
CHEMBL121191 6.41 Ki 393.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
5
5.5
5
6.0
2
6.5
3
7.0
2
7.5
2
8.0
1
8.5
0
9.0
1
9.5
pChEMBL
Assay Landscape

Assay Landscape

12
Total Assays
35
Tested Compounds
1
Assay Types
Binding — 12 assays, 35 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 8 28 6.1
single protein format 4 7 5.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine